Xtant Medical Holdings, Inc.
XTNT- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001453593
No open-market purchases or sales by Xtant Medical Holdings, Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $33.8M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Xtant Medical Holdings, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- −3 vs. Q2 2021
- Shares held
- 80.5M
- −2.20M (−2.7%) vs. Q2 2021
- Total value
- $89.4M
- −$45.5M (−33.7%) vs. Q2 2021
- New holders
- 0
- 4 more added
- Sold out
- 3
- 7 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XTNT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 32 | $33.8M |
| Q1 2026 | 34 | $45.1M |
| Q4 2025 | 35 | $63.8M |
| Q3 2025 | 30 | $52.0M |
| Q2 2025 | 30 | $59.1M |
| Q1 2025 | 28 | $45.3M |
| Q4 2024 | 30 | $42.8M |
| Q3 2024 | 28 | $66.1M |
| Q2 2024 | 27 | $56.7M |
| Q1 2024 | 33 | $105.7M |
| Q4 2023 | 31 | $101.9M |
| Q3 2023 | 28 | $99.3M |
| Q2 2023 | 19 | $76.0M |
| Q1 2023 | 21 | $52.2M |
| Q4 2022 | 19 | $54.1M |
| Q3 2022 | 18 | $58.8M |
| Q2 2022 | 18 | $41.9M |
| Q1 2022 | 19 | $54.8M |
| Q4 2021 | 22 | $45.2M |
| Q3 2021 | 17 | $89.4M |
| Q2 2021 | 20 | $134.8M |
| Q1 2021 | 21 | $175.8M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Xtant Medical Holdings, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 72,873,494 | $80.9M | 0.90% | 00.0% | Unchanged |
| Altium Capital Management LP | 6,254,458 | $6.94M | 1.85% | −2,038,144−24.6% | Reduced |
| Renaissance Technologies LLC | 680,800 | $756.0K | 0.00% | −331,200−32.7% | Reduced |
| Bridgeway Capital Management, LLC | 495,900 | $550.0K | 0.01% | +204,998+70.5% | Added |
| Vanguard Group Inc | 48,236 | $54.0K | 0.00% | +4,066+9.2% | Added |
| Tower Research Capital LLC (TRC) | 31,662 | $35.0K | 0.00% | +23,432+284.7% | Added |
| Virtu Financial LLC | 24,599 | $27.0K | 0.00% | −12,014−32.8% | Reduced |
| BlackRock Inc. | 22,473 | $25.0K | 0.00% | −488−2.1% | Reduced |
| State Street Corp | 22,800 | $25.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 21,204 | $23.0K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 20,069 | $22.0K | 0.00% | −10.0% | Reduced |
| Victory Capital Management Inc | 12,876 | $14.0K | 0.00% | −650−4.8% | Reduced |
| Bank of America Corp | 47 | $0 | 0.00% | −25−34.7% | Reduced |
| Wells Fargo & Company | 85 | $0 | 0.00% | +57+203.6% | Added |
| Morgan Stanley | 29 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 25 | $0 | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 120 | $0 | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −36,531−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −15,472−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −26−100.0% | Sold out |